Group One Trading’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-40,400
Closed -$31K 8574
2022
Q2
$31K Sell
40,400
-4,500
-10% -$4.01K ﹤0.01% 5964
2022
Q1
$48K Buy
44,900
+22,400
+100% +$40.7K ﹤0.01% 6127
2021
Q4
$43K Sell
22,500
-174,500
-89% -$418K ﹤0.01% 6456
2021
Q3
$593K Sell
197,000
-213,800
-52% -$761K ﹤0.01% 3996
2021
Q2
$1.61M Buy
410,800
+34,200
+9% +$142K ﹤0.01% 2879
2021
Q1
$1.91M Buy
376,600
+299,600
+389% +$1.55M ﹤0.01% 2520
2020
Q4
$315K Buy
77,000
+900
+1% +$4.42K ﹤0.01% 3700
2020
Q3
$370K Buy
76,100
+22,400
+42% +$122K ﹤0.01% 3115
2020
Q2
$298K Buy
53,700
+4,400
+9% +$20.2K ﹤0.01% 3055
2020
Q1
$162K Buy
+49,300
New +$260K ﹤0.01% 2921
2019
Q1
Sell
-22,800
Closed -$57K 5554
2018
Q4
$57K Buy
+22,800
New +$134K ﹤0.01% 3496
2018
Q3
Sell
-3,600
Closed -$13K 5764
2018
Q2
$13K Buy
+3,600
New +$16.7K ﹤0.01% 4544

Group One Trading's AGTC Position: Q4 2022 in Review

Group One Trading sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 4,080 shares — an estimated $1K sold.

Group One Trading first reported a position in AGTC in Q2 2020 and held it in 10 quarters. The position peaked at $372K in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Group One Trading reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 4,080 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $1K.
  • Group One Trading first reported a position in Applied Genetic Technologies Corporation in Q2 2020 and held it in 10 quarters.
  • Group One Trading's Applied Genetic Technologies Corporation position peaked at $372K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.